# Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer

> **NCT06017557** · NA · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 151 (estimated)

## Conditions studied

- Ovarian Cancer Stage III
- Ovarian Cancer Stage IV

## Interventions

- **DIAGNOSTIC_TEST:** Artificial Intelligence

## Key facts

- **NCT ID:** NCT06017557
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-02
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-09-01
- **Target enrollment:** 151 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06017557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06017557, "Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06017557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*